Napredna pretraga

Pregled bibliografske jedinice broj: 212449

Nm23-H1 and colon adenocarcinoma


Kapitanović, Sanja; Čačev, Tamara; Radošević, Senka; Berković, Maja; Pavelić, Krešimir; Spaventi, Radan.
Nm23-H1 and colon adenocarcinoma // 10th International Congress of Human Genetics : abstracts ; u: European Journal of Human Genetics / ICHG (ur.).
Wien: Nature publishing group, 2001. str. 101-101 (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Nm23-H1 and colon adenocarcinoma

Autori
Kapitanović, Sanja ; Čačev, Tamara ; Radošević, Senka ; Berković, Maja ; Pavelić, Krešimir ; Spaventi, Radan.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
10th International Congress of Human Genetics : abstracts ; u: European Journal of Human Genetics / ICHG - Wien : Nature publishing group, 2001, 101-101

Skup
International Congress of Human Genetics (10 ; 2001)

Mjesto i datum
Beč, Austrija, 15-19.05.2001.

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Nm23-H1; colon adenocarcinoma

Sažetak
Nm32 gene was originally identified by differential hybridisation of K-1735 melanoma cell line clones of varying metastatic potential. A tumor metastases-supressor function was implicated by the reduced expression of nm23 in highly metastatic sublines compared with non-metastatic sublines derived from the same K-1735 clone. The purpose of this study was to evaluate whether the expression of the nm23-H1 protein or loss of heterozygosity (LOH) of the nm23-H1 gene is associated with tumor stage and grade of tumor differentiation. We also investigated the correlation of nm23-H1 expression with 5-year survival. Of 102 adenocarcinomas that were examined, 41% showed a weak positive immunostaining for nm23-H1 protein. The most nm23-H1 positive tumors were in Dukes' B (67%) and in the well differentiated tumors (65%). Statistical analysis showed that there was no statistically significant difference in survival between the patients with nm23-H1 positive tumors and patients with tumors that were not stained for nm23-H1 protein. To analyze LOH at the nm23-H1 gene we used VNTR marker located in untranslated 5' region of the nm23-H1. At this nm23-H1 locus 60% of samples were informative and 33% of them demonstrated LOH. The nm23-H1 was more frequent in tumors that were larger than 5 cm than in smaller ones. Positive correlation was found between the nm23-H1 LOH and histological grade as well as between the nm23-H1 LOH and Dukes' stage of tumor samples.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekt / tema
0098108

Ustanove
Pliva-Istraživački institut,
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE